KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review

BACKGROUND: Epidermal growth factor receptor (EGFR) signaling is one of the most promising targets for molecular-targeted therapies in esophageal squamous cell carcinoma (ESCC). Thus, the molecular diagnosis of KRAS and BRAF mutations is clinically important in therapeutic decision making. However,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shigaki, Hironobu, Baba, Yoshifumi, Watanabe, Masayuki, Miyake, Keisuke, Murata, Asuka, Iwagami, Shiro, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Yoshida, Naoya, Baba, Hideo
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2012
Assuntos:
Translational Research and Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853643/
https://ncbi.nlm.nih.gov/pubmed/23274581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-012-2819-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados